Compounds > hyaluronoglucosaminidase
Page last updated: 2024-08-22

hyaluronoglucosaminidase and Common Variable Immunodeficiency

hyaluronoglucosaminidase has been researched along with Common Variable Immunodeficiency in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Danieli, MG; Pedini, V; Savore, I1
Jahnz-Różyk, K; Więsik-Szewczyk, E1
Wasserman, RL1
Danieli, MG; Morariu, R; Pulvirenti, F; Quinti, I; Rocchi, V1
Carne, E; El-Shanawany, T; Jolles, S; Knight, E; Novak, B; Pickersgill, T; Williams, P1

Reviews

1 review(s) available for hyaluronoglucosaminidase and Common Variable Immunodeficiency

ArticleYear
Overview of recombinant human hyaluronidase-facilitated subcutaneous infusion of IgG in primary immunodeficiencies.
    Immunotherapy, 2014, Volume: 6, Issue:5

    Topics: Clinical Trials, Phase III as Topic; Common Variable Immunodeficiency; Humans; Hyaluronoglucosaminidase; Immunoglobulin G; Infusions, Subcutaneous; Recombinant Proteins

2014

Other Studies

4 other study(ies) available for hyaluronoglucosaminidase and Common Variable Immunodeficiency

ArticleYear
Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency.
    The Israel Medical Association journal : IMAJ, 2017, Volume: 19, Issue:7

    Topics: Anemia, Hemolytic, Autoimmune; Antigens, Neoplasm; Common Variable Immunodeficiency; Female; Glucocorticoids; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Immunoglobulins; Injections, Subcutaneous; Middle Aged; Prednisone; Purpura, Thrombocytopenic, Idiopathic

2017
A case report of pregnancy in a patient with common variable immunodeficiency emphasizing the need for personalized immunoglobulin replacement.
    Medicine, 2018, Volume: 97, Issue:44

    Topics: Adult; Antigens, Neoplasm; Common Variable Immunodeficiency; Female; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Immunization, Passive; Immunoglobulin G; Injections, Subcutaneous; Pregnancy

2018
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies.
    Immunotherapy, 2016, Volume: 8, Issue:9

    Topics: Adult; Agammaglobulinemia; Common Variable Immunodeficiency; Diabetes Mellitus, Type 1; Female; Genetic Diseases, X-Linked; Granulomatous Disease, Chronic; Humans; Hyaluronoglucosaminidase; Immunization, Passive; Infusions, Subcutaneous; Malabsorption Syndromes; Medication Adherence; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Self Administration

2016
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin home therapy in a patient with primary immunodeficiency.
    Journal of clinical pathology, 2010, Volume: 63, Issue:9

    Topics: Adult; Common Variable Immunodeficiency; Drug Administration Schedule; Female; Humans; Hyaluronoglucosaminidase; Immunization, Passive; Injections, Subcutaneous; Self Administration

2010